In order to further dissect our immunohistochemical results, we analyzed the co-expression of CD26 with the markers of the epithelial-to-mesenchymal transition, a pathway that has been shown to promote tumor initiation, progression, and resistance to therapies (28). Here, DPP4 is linked to neoplasm.